Aethlon Medical (STU:EJU1) EPS (Basic): €-42.36 (TTM As of Mar. 2026)

What is Aethlon Medical EPS (Basic)?

Aethlon Medical STU:EJU1 23 EPS (Basic) is €-42.36 as of Mar. 2026. GuruFocus rates STU:EJU1 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review.

Aethlon Medical's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €-1.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-42.36.

Aethlon Medical's EPS (Diluted) for the three months ended in Mar. 2026 was €-1.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-42.36.

Aethlon Medical's EPS without NRI for the three months ended in Mar. 2026 was €-1.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -42.36.

During the past 3 years, the average EPS without NRI Growth Rate was 71.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 51.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 44.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Aethlon Medical's highest 3-Year average EPS without NRI Growth Rate was 71.60% per year. The lowest was -846.20% per year. And the median was 25.70% per year.

Aethlon Medical (STU:EJU1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aethlon Medical EPS (Basic) Related Terms

Aethlon Medical EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Aethlon Medical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aethlon Medical EPS (Basic) Chart

Aethlon Medical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

EPS (Basic)

Get a 7-Day Free Trial

-515.74

-437.86

-357.60

-79.34

-9.18

Aethlon Medical Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-34.61	-7.37	-31.87	-2.09	-1.04

23GF Score

Aethlon Medical Inc STU:EJU1

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aethlon Medical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aethlon Medical's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.186	-	0)	/	0.674
	=	-9.18

Aethlon Medical's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.63	-	0)	/	1.570
	=	-1.04

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-42.36

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €-42.36 mean?

Aethlon Medical (STU:EJU1) has a EPS (Basic) of €-42.36 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aethlon Medical and its competitors.

Is Aethlon Medical's EPS (Basic) too high?

Aethlon Medical's current EPS (Basic) is €-42.36. Overall, Aethlon Medical has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.

How does Aethlon Medical's EPS (Basic) compare to RMSL and BTCY?

Aethlon Medical's EPS (Basic) of €-42.36 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aethlon Medical and its competitors. Aethlon Medical's current EPS (Basic) is €-42.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aethlon Medical stock overvalued right now?

Aethlon Medical (STU:EJU1) has a current EPS (Basic) of €-42.36. The current EPS (Basic) is €-42.36. Aethlon Medical's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Aethlon Medical (STU:EJU1), the current EPS (Basic) is €-42.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aethlon Medical Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies RMSL BTCY IVF AMIX VTAK VYCO ADMT BJDX NUWE ITOC ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges AEMD:USA

Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121

Website https://www.aethlonmedical.com

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

23GF Score

Get the complete analysis for STU:EJU1

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.40

Price

View STU:EJU1 Analysis

See EPS (Basic) data for all stocks →